Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
Sarepta Therapeutics
Biotech
Sarepta's big bet on Arrowhead's siRNA assets yields early data
Sarepta shared clinical data on two siRNA candidates, delivering an early look at the wisdom of its decision to bet big on Arrowhead’'s pipeline.
Nick Paul Taylor
Mar 25, 2026 9:35am
Sarepta CEO to step down as DM1 hits home—Chutes & Ladders
Feb 27, 2026 8:30am
Fierce Pharma
Sarepta CEO to retire, citing 'shocking and ironic twist of fate'
Feb 26, 2026 11:30am
Fierce Biotech's Rotten Tomatoes of 2025
Dec 16, 2025 4:30am
Dyne readies FDA push after DMD exon 51 med excels in trial
Dec 8, 2025 10:50am
Sarepta shares safety update on DM1 RNA med
Nov 24, 2025 4:00pm